Affiliation:
1. Medical University of Vienna
Abstract
Cardiac transplantation is an established therapy for end-stage heart failure. The number of heart transplant procedures performed worldwide has remained relatively unchanged in recent years. Although mortality rates on the waiting list have improved due to improved ventricular assist devices and rhythm correction techniques, it remains imperative to maximize use of all potential donor hearts. The recipient now presents with multiple complexities. The continued divergence between the rising number of transplant candidates added to the transplant waiting list and the number of suitable organ donors has increased pressure on clinicians to maximize the use of available thoracic organs for transplantation.
Publisher
V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs
Subject
Transplantation,Immunology and Allergy
Reference23 articles.
1. D’Allesandro C, Golmard JL, Barreda E, Laali M, Makris CE, Leprince P et al.Predictive risk factors for primary graft failure requiring temporary extracorporeal membrane oxygenation support after cardiac transplantation in adults. Eur J Cardiothorac Surg. 2011; 40: 962–969.
2. Lund LH, Edwards LB, Kucheryavaya AY et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-first Official Adult Heart Transplant Report-2014; focus theme: retransplantation. J Heart Lung Transplant. 2014; 33: 996–1008.
3. Organ Procurement and Transplantation Network. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/# Accessed 6 August 2017.
4. ColvinAdams M, Smithy JM, Heubner BM et al. OPTN/SRTR 2012 Annual Data Report: heart. Am J Transplant. 2014; 14 (Suppl 1): 113–138.
5. Mehra MR, Canter CE, Hannan MM et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. 2016; 35: 1–23.